Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of.

An Act To Be Known As The Ibogaine Drug Development Clinical Trial Act; To Authorize The Establishment Of A Consortium To Apply For Selection By The State Department Of Health To Conduct A Drug Development Clinical Trial With Ibogaine And Secure The United States Food And Drug Administration's (fda) Approval Of Ibogaine As A Medication For The Treatment Of Opioid Use Disorder, Co-occurring Substance Use Disorder, And Any Other Neurological Or Mental Health Condition For Which Ibogaine Demonstrat…